Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 2021

View Archived Issues

mRNA vaccine can tamp down immunity, too

Amnion secretome neuroprotection takes all parts

M. tuberculosis-derived rRv-2626c-CA peptide protects mice from sepsis

Finerenone lowers risk of CKD progression and cardiovascular events in CKD with type 2 diabetes

Verve Therapeutics selects VERVE-101 as its lead gene editing therapy candidate

Initiation of pivotal global study evaluating CLR-131 in Waldenstrom's macroglobulinemia

Veralox submits IND to the FDA for VLX-1005

Dana-Farber Cancer Institute synthesizes new EGFR inhibitors

Pfizer and CTxT Pty divulge new KAT inhibitors

U.S. researchers disclose compounds for West Nile viral infection

Anti-CLDN18.2/CD47 antibodies presented by Phanes Therapeutics

Alzheimer's disease subtypes may explain, improve clinical results

Rezolute initiates first-in-human study of RZ-402

New adenosine A2A receptor antagonists presented by AMMS

Positive topline data from ongoing phase II LiFT study of LPCN-1144

Successful preclinical data for ImmCelz as treatment of stroke

Japanese phase III trial of AJM-300 in ulcerative colitis meets primary endpoint

Novel AAV gene therapy rescues hearing loss in Syne4-/- mice

Apabetalone protects from heart failure in patients with T2D and ACS

JD-1 preferentially targets cell membranes of Gram-negative bacteria

Dovobet Foam approved in Japan for psoriasis

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...